Literature DB >> 7564345

Nitric oxide synthase blockade and renal vascular responses to norepinephrine and endothelin-1 in conscious dogs.

S M Fitzgerald1, R G Evans, I J Christy, W P Anderson.   

Abstract

The effects of inhibiting nitric oxide (NO) synthase with NG-nitro-L-arginine (L-NNA) on renal vasoconstrictor responses to intrarenally administered norepinephrine (NE) and endothelin-1 (ET-1) were studied in conscious dogs. NE was infused into the renal artery at 0.02, 0.05, 0.1, and 0.2 micrograms/kg/min (15 min at each rate), with the dogs (n = 5) pretreated with either L-NNA 10 mg/kg intravenously (i.v.) or vehicle (250 mM NaHCO3 solution at 2 ml/kg i.v.) NE produced dose-related decreases in renal blood flow (RBF) and renal vascular conductance that were significantly greater after L-NNA pretreatment than after vehicle. ET-1 was infused intrarenally at 2.7 ng/kg/min for 45 min with the dogs (n = 5) pretreated with either L-NNA 10 mg/kg i.v. or vehicle. ET-1 caused a progressive decrease in RBF and renal vascular conductance. In contrast to the results with NE, RBF and renal vascular conductance decreased significantly less in response to ET when the dogs were pretreated with L-NNA as compared with pretreatment with vehicle. Therefore, blockade of NO synthase augmented NE-induced but not ET-induced renal vasoconstriction. The results therefore suggest that NO may act to lessen the renal vascular effects of NE, but this effect does not appear to be generalised to all vasoconstrictors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564345     DOI: 10.1097/00005344-199506000-00018

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  1 in total

1.  Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.